These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30336754)

  • 1. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
    Wu Q; Yang Q; Sun H
    Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
    Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
    Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
    Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
    Front Immunol; 2021; 12():663192. PubMed ID: 34054830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
    El-Banna HS; El Khouly RM; Gado SE
    Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
    Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus.
    Wang H; Cao J; Lai X
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R; Panda AK; Das BK
    Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
    Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
    Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
    Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
    Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
    Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.
    Myngbay A; Bexeitov Y; Adilbayeva A; Assylbekov Z; Yevstratenko BP; Aitzhanova RM; Matkarimov B; Adarichev VA; Kunz J
    Front Immunol; 2019; 10():1353. PubMed ID: 31249576
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity.
    Houssiau FA; Lefebvre C; Vanden Berghe M; Lambert M; Devogelaer JP; Renauld JC
    Lupus; 1995 Oct; 4(5):393-5. PubMed ID: 8563734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study.
    Fayed A; El Menyawi MM; Ghanema M; Shaker O; Elgohary R
    Reumatismo; 2020 Nov; 72(3):145-153. PubMed ID: 33213127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
    Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.
    Chun HY; Chung JW; Kim HA; Yun JM; Jeon JY; Ye YM; Kim SH; Park HS; Suh CH
    J Clin Immunol; 2007 Sep; 27(5):461-6. PubMed ID: 17587156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.